Vaginal Infection
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
BioperfectusChina - Shanghai
1 programResearch on Vaginal Microbiota Evaluation Unified Standards Based on Gram StainingN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Allergy TherapeuticsTOL-463 Vaginal ovule
BioperfectusResearch on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining
Carbon BiosciencesVaginal swab for RT-PCR
Clinical Trials (3)
Total enrollment: 5,736 patients across 3 trials
Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463
Start: Apr 2013Est. completion: May 201426 patients
Phase 1Completed
NCT05997160BioperfectusResearch on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining
Research on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining
Start: Sep 2023Est. completion: Jun 20255,590 patients
N/AUnknown
Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge
Start: Oct 2022Est. completion: Oct 2025120 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.